secwatch.observer — SEC 8-K summary
======================================

Issuer:     Allarity Therapeutics, Inc. (ALLR)
CIK:        0001860657
Form:       8-K
Filed at:   2024-04-04T23:59:59+00:00
Accession:  0001213900-24-030473
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 3.03, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Allarity Therapeutics approves 1-for-20 reverse stock split effective April 9, 2024
--------------------------------------------------------------------------------

- Stockholders approved 1-for-20 reverse stock split at April 1 special meeting; ratio set by Board.
- Reverse split effective April 9, 2024 at 9:30 a.m. ET; trading symbol ALLR unchanged; new CUSIP 016744401.
- No fractional shares issued; any fractional rounded up to next whole number. Authorized shares unchanged at 750M.
- Amendment to 2021 Equity Incentive Plan passed, adding 1,000,000 authorized shares.
- Adjournment proposal also passed but not needed as reverse split proposal already approved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860657/000121390024030473/0001213900-24-030473-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860657/000121390024030473/ea0203322-8k_allarity.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-030473

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer